Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Solid Biosciences Inc. Director's Dealing 2023

Feb 1, 2023

33003_dirs_2023-01-31_245c4eb5-448c-488b-a18c-9e8d9d529ef9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2023-01-27

Reporting Person: Ganot Ilan (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-01-27 Common Stock M 388 Acquired 1519 Indirect
2023-01-27 Common Stock S 141 $7.49 Disposed 1378 Indirect
2023-01-27 Common Stock M 3883 Acquired 85973 Direct
2023-01-27 Common Stock S 1382 $7.49 Disposed 84591 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-01-27 Restricted Stock Units $ M 388 Disposed Common Stock (388) Indirect
2023-01-27 Restricted Stock Units $ M 3883 Disposed Common Stock (3883) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 19394 Indirect

Footnotes

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: Includes 1,462 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on November 30, 2022.

F3: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1).

F4: Includes 490 shares of common stock and 1,462 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 31, 2022 and November 30, 2022, respectively.

F5: Represents 81,931 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.

F6: Represents 19,394 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.

F7: On January 27, 2022 (the "Grant Date"), Ms. Ganot was granted 1,553 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.

F8: On the Grant Date, the reporting person was granted 15,533 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.